Pancreatic Cancer Research

ResearcherMayo ClinicNo recent work listed

Michael H. Muders

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3020-9692; OpenAlex author ID A5064359106. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2011: 2 papers · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper

Papers 3

  1. Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma exerts multiple cellular and molecular antitumor effects. Co-author DOI 10.1038/s41598-019-51881-8↗
  2. Inactivation of Brca2 promotes Trp53-associated but inhibits KrasG12D-dependent pancreatic cancer development in mice. Co-author DOI 10.1053/j.gastro.2010.12.039↗
  3. Neuropilin and neuropilin associated molecules as new molecular targets in pancreatic adenocarcinoma. Co-author DOI 10.2174/187152011795677481↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hannes Borchardt · 1 shared paper, 2019 · strength 0.12
  2. Achim Michael Aigner · 1 shared paper, 2019 · strength 0.12
  3. Thomas C. Smyrk · 1 shared paper, 2011 · strength 0.02
  4. Matthew Rowley · 1 shared paper, 2011 · strength 0.02
  5. Lin Yang · 1 shared paper, 2011 · strength 0.02
  6. Fergus Joseph Couch · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.